Deadline: 31st of August 2022
We would like to draw your kind attention to the ‘’Prof. Dr. Mahfouz Kassem Scholarship’’. The Call for the academic year 2023 is currently open for application!
With this scholarship in pharmaceutical research the DAAD-Stiftung awards the Prof. Dr. Mahfouz Kassem Scholarship for postdoctoral researchers and doctoral candidates/PhD students who have graduated with a master’s degree or a diploma by the time the scholarship starts enabling them to conduct research and further their training in Germany. The scholarship is also intended to support networking between Egyptian and German colleagues in the discipline.
The DAAD-Stiftung pursues similar objectives to those of its trustee, the DAAD e.V. with the difference that the funding available is donated by private individuals. The DAAD-Stiftung and its trustee collaborate closely in administering this funding.
Eligible to apply are excellently qualified doctoral candidates and young academics conducting research in fields relevant to the pharmaceuticals industry in Egypt.
Applicants must have graduated with a Master’s or Diplom degree and may not be currently studying or employed at an institution in Germany. A further requirement is that the result of the research project is useful in the broadest sense for the pharmaceutical industry in Egypt. Applicants can be a maximum of 31 years old at the time of application.
The scholarship is awarded for a minimum period of two and a maximum period of three months.
Kindly note, that the deadline for application is the 31st of August 2022. The application should be submitted online through the DAAD portal!
You can find detailed information about this scholarship under the following link: Prof. Dr Mahfouz Kassem Scholarship, offered by the DAAD-Stiftung | DAAD Egypt
If you have any questions, we will answer them gladly.
In this regard, we highly appreciate your support by disseminating the announcement to the target segments and all candidates who might be interested to conduct their research in Germany.
N.B. Content of this announcement can be changed without prior notice.